Go to main content
Italy

Product Details

BESREMi® is indicated as monotherapy in adults for the treatment of Polycythaemia vera without symptomatic splenomegaly.

BESREMi® 250 micrograms/0.5 mL solution for injection in pre-filled pen 

BESREMi® 500 micrograms/0.5 mL solution for injection in pre-filled pen

Drug Facts 

Ropeginterferon alfa-2b